Index S&P 500
P/E 26.07
EPS (ttm) 9.45
Insider Own 0.42%
Shs Outstand 106.76M
Perf Week 0.75%
Market Cap 25.43B
Forward P/E 15.32
EPS next Y 16.08
Insider Trans -2.22%
Shs Float 102.83M
Perf Month 4.41%
Income 1.02B
PEG 2.46
EPS next Q 7.05
Inst Own 95.52%
Short Float / Ratio 0.95% / 1.57
Perf Quarter 19.12%
Sales 9.35B
P/S 2.72
EPS this Y 5.07%
Inst Trans -0.48%
Short Interest 0.97M
Perf Half Y 11.84%
Book/sh 91.08
P/B 2.70
EPS next Y 14.13%
ROA 3.53%
Target Price 248.71
Perf Year 3.27%
Cash/sh 14.68
P/C 16.78
EPS next 5Y 10.60%
ROE 10.74%
52W Range 195.29 - 258.93
Perf YTD 0.70%
Dividend 3.23
P/FCF 26.44
EPS past 5Y 16.62%
ROI 7.02%
52W High -4.88%
Beta 0.73
Dividend % 1.31%
Quick Ratio -
Sales past 5Y 1.46%
Gross Margin -
52W Low 26.12%
ATR 3.72
Employees 46600
Current Ratio 1.05
Sales Q/Q 10.18%
Oper. Margin 18.72%
RSI (14) 69.67
Volatility 1.50% 1.38%
Optionable Yes
Debt/Eq 0.63
EPS Q/Q -24.33%
Profit Margin 10.92%
Rel Volume 1.40
Prev Close 240.77
Shortable Yes
LT Debt/Eq 0.55
Earnings Oct 26 BMO
Payout 36.41%
Avg Volume 618.86K
Price 246.30
Recom 2.62
SMA20 2.53%
SMA50 9.98%
SMA200 9.67%
Volume 869,111
Change 2.30%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-08-23 Downgrade
BMO Capital Markets
Market Perform → Underperform
$230 → $205
Jul-27-23 Downgrade
Raymond James
Strong Buy → Outperform
$260
Jun-20-23 Initiated
Morgan Stanley
Equal-Weight
$251
Feb-27-23 Upgrade
Goldman
Neutral → Buy
$290
Jan-20-23 Initiated
BMO Capital Markets
Market Perform
$260
Jan-18-23 Upgrade
Keefe Bruyette
Mkt Perform → Outperform
$303
Dec-15-22 Initiated
Citigroup
Neutral
$247
Oct-13-22 Upgrade
Piper Sandler
Neutral → Overweight
$250
Sep-26-22 Initiated
Credit Suisse
Outperform
$288
Jul-12-22 Initiated
Goldman
Neutral
$227
Apr-11-22 Resumed
BofA Securities
Underperform
$245
Feb-09-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$284 → $240
Dec-16-21 Initiated
Evercore ISI
In-line
$240
Nov-19-21 Initiated
Jefferies
Hold
$258
Oct-20-21 Downgrade
Wolfe Research
Outperform → Peer Perform
$283 → $244
Sep-10-21 Reiterated
MKM Partners
Buy
$250 → $285
Aug-17-21 Initiated
Wolfe Research
Outperform
$261
Aug-03-21 Upgrade
MKM Partners
Neutral → Buy
Feb-11-21 Upgrade
Raymond James
Outperform → Strong Buy
Jan-11-21 Upgrade
Raymond James
Mkt Perform → Outperform
Show Previous Ratings
Today 07:44AM
Nov-29-23 09:06AM
06:00AM
Nov-27-23 12:46PM
Nov-14-23 12:50PM
04:03PM
Loading…
Nov-13-23 04:03PM
04:03PM
Nov-08-23 05:41AM
Nov-02-23 11:34AM
(Investor's Business Daily)
Nov-01-23 07:00AM
Oct-28-23 02:32PM
Oct-27-23 12:14PM
Oct-26-23 08:24PM
(Morningstar Research) +10.27%
10:52AM
09:30AM
07:50AM
Loading…
07:50AM
07:42AM
07:15AM
06:00AM
Oct-23-23 12:00PM
07:56AM
Oct-20-23 09:45AM
Oct-19-23 10:01AM
Oct-17-23 10:04AM
Oct-16-23 04:57AM
Oct-12-23 09:56AM
08:04AM
Oct-11-23 02:59AM
Oct-10-23 04:12PM
Oct-06-23 05:04AM
02:58PM
Loading…
Oct-04-23 02:58PM
Sep-29-23 07:06AM
Sep-28-23 07:09AM
Sep-26-23 10:53AM
Sep-21-23 09:04AM
Sep-19-23 07:32PM
Sep-11-23 11:01AM
Aug-31-23 05:00PM
Aug-27-23 09:31AM
Aug-23-23 07:15AM
Aug-16-23 11:22AM
Aug-15-23 09:30AM
Aug-10-23 07:06AM
Aug-09-23 09:00AM
Aug-08-23 08:18PM
07:32PM
02:19AM
Aug-01-23 03:35PM
Jul-28-23 12:12PM
Jul-27-23 12:16PM
12:00PM
09:30AM
07:15AM
06:00AM
Jul-26-23 09:32AM
Jul-25-23 12:15PM
05:46AM
Jul-24-23 04:21PM
Jul-23-23 08:34AM
Jul-20-23 10:02AM
Jul-13-23 10:54AM
Jul-11-23 10:58AM
06:15AM
Jul-07-23 10:32AM
09:00AM
Jul-06-23 09:05AM
Jul-03-23 01:42PM
Jun-29-23 10:58AM
Jun-21-23 08:00PM
Jun-09-23 09:03AM
07:59AM
Jun-07-23 05:30PM
Jun-05-23 12:25PM
May-25-23 10:34AM
May-24-23 12:04PM
May-18-23 04:05PM
May-10-23 06:01PM
May-09-23 11:40AM
Apr-30-23 08:08AM
Apr-27-23 02:18PM
01:04PM
09:30AM
07:15AM
06:00AM
Apr-26-23 08:00PM
Apr-25-23 06:21AM
Apr-20-23 10:02AM
Apr-18-23 04:02AM
04:00AM
Apr-13-23 04:19PM
Apr-12-23 10:04AM
Apr-07-23 09:00AM
Apr-04-23 07:50AM
Mar-25-23 08:46AM
Mar-17-23 06:59AM
Mar-08-23 04:30AM
Mar-07-23 11:38AM
Mar-02-23 09:55AM
Feb-23-23 09:05AM
Feb-16-23 11:50AM
Willis Towers Watson Plc engages in the provision of advisory, broking, and solutions services. It operates through the following segments: Human Capital and Benefits (HCB), Corporate Risk and Broking (CRB), Investment, Risk and Reinsurance (IRR), and Benefits Delivery and Administration (BDA). The HCB segment provides advice, broking, solutions, and software for employee benefit plans, human resources organizations, and management teams. The CRB segment offers a range of risk advice, insurance brokerage, and consulting services to clients ranging from small businesses to corporations. The IRR segment focuses on helping clients free up capital and manage investment complexity. The BDA segment covers medical and ancillary benefit exchange and outsourcing services to active employees and retirees across both the group and individual markets. The company was founded in 1828 and is headquartered in London, the United Kingdom.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Thomson-Hall Pamela Head of International Nov 09 Sale 238.87 330 78,827 3,324 Nov 13 04:02 PM Gebauer Julie Jarecke Head of Health, Wealth &Career Jul 03 Sale 231.69 2,000 463,384 75,240 Jul 05 04:01 PM Pullum Anne Head of Europe Jun 07 Sale 224.45 5,000 1,122,230 12,791 Jun 09 04:00 PM Gebauer Julie Jarecke Head of Health, Wealth &Career Jun 01 Sale 218.35 2,500 545,868 77,240 Jun 01 04:01 PM Gebauer Julie Jarecke Head of Health, Wealth &Career May 01 Sale 231.44 2,500 578,590 79,740 May 02 04:01 PM Krasner Andrew Jay Chief Financial Officer Apr 17 Option Exercise 0.00 2 0 11,647 Apr 19 09:10 PM Bodnar Anne Donovan Chief Administrative Officer Apr 17 Option Exercise 0.00 1 0 9,105 Apr 19 09:09 PM Garrard Adam Head of Risk & Broking Apr 17 Option Exercise 0.00 1 0 18,384 Apr 19 09:08 PM Qureshi Imran Ahmed Head of North America Apr 17 Option Exercise 0.00 1 0 3,535 Apr 19 09:03 PM Furman Matthew General Counsel Apr 17 Option Exercise 0.00 1 0 31,834 Apr 19 09:04 PM Hess Carl Aaron Chief Executive Officer Apr 17 Option Exercise 0.00 9 0 73,376 Apr 19 09:03 PM Gebauer Julie Jarecke Head of Health, Wealth &Career Apr 17 Option Exercise 0.00 1 0 82,241 Apr 19 09:02 PM Pullum Anne Head of Europe Apr 17 Option Exercise 0.00 1 0 17,792 Apr 19 09:01 PM Gebauer Julie Jarecke Head of Health, Wealth &Career Apr 03 Sale 232.38 2,500 580,941 82,312 Apr 04 05:08 PM Furman Matthew General Counsel Mar 03 Option Exercise 116.68 12,571 1,466,784 41,071 Mar 07 05:00 PM Gebauer Julie Jarecke Head of Health, Wealth &Career Mar 01 Sale 233.41 2,500 583,514 82,550 Mar 02 04:00 PM Gebauer Julie Jarecke Head of Health, Wealth &Career Feb 14 Sale 246.70 3,000 740,103 85,050 Feb 15 04:01 PM Bodnar Anne Donovan Chief Administrative Officer Feb 09 Sale 253.94 5,000 1,269,715 9,164 Feb 10 04:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite